IDEXX Laboratories Inc., a global leader in pet healthcare innovation, has released its 2024 Corporate Responsibility Report, detailing progress in areas aligned with corporate responsibility and sustainability. The report highlights several initiatives, including the launch of the IDEXX inVue Dx™ Cellular Analyzer and IDEXX Cancer Dx™ testing for early cancer detection in canines. The company also facilitated access to care for over 79,000 animals in underserved communities in 2024 and provided $5.5 million worth of educational credits to veterinary professionals. Additionally, IDEXX reported over 86,000 hours of employee learning and development and exceeded its 2025 volunteer hour goal. On environmental efforts, the company signed power purchase agreements for clean energy and increased the presence of electric and hybrid vehicles in its fleet.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.